MDC1-AS, An antisense long noncoding RNA, Regulates cell proliferation of glioma

Biomedicine and Pharmacotherapy

Volumn 81, Issue , 2016, Pages 203-209

  Yue, Hongsheng ^a   Zhu, Jie ^a   Xie, Shugang ^b   Li, Fangfang ^c   Xu, Qun ^d  

^a JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b Shanghe County People's Hospital   (China)

^c SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^d Ji'nan Vocational College of Nursing   (China)

Author keywords

Cell proliferation; Glioma; Long non coding RNA MDC1 AS; MDC1

Indexed keywords

LONG UNTRANSLATED RNA; MEDIATOR OF DNA DAMAGE CHECKPOINT PROTEIN 1; UNCLASSIFIED DRUG; LONG NON-CODING RNA MDC1-AS, HUMAN;

ARTICLE; CANCER CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GAIN OF FUNCTION MUTATION; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; LOSS OF FUNCTION MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; BRAIN TUMOR; CELL CYCLE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

BRAIN NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; RNA, LONG NONCODING;

EID: 84963611508     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.03.002     Document Type: Article

References (33)

1. Sathornsumetee S., Rich J.N. New treatment strategies for malignant gliomas. Expert Rev. Anticancer Ther. 2006, 6:1087-1104.
2. Ehtesham M., Stevenson C.B., Thompson R.C. Stem cell therapies for malignant glioma. Neurosurg. Focus 2005, 19:E5.
3. Qi Y., Ooi H.S., Wu J., Chen J., Zhang X., Tan S., Zhao X., et al. MALAT1 long ncRNA promotes gastric cancer metastasis by suppressing PCDH10. Oncotarget 2016.
4. Zhou M., Wang X., Shi H., Cheng L., Wang Z., Zhao H., Sun J., et al. Characterization of long non-coding RNA-associated ceRNA network to reveal potential prognostic lncRNA biomarkers in human ovarian cancer. Oncotarget 2016.
5. Pickard M.R., Williams G.T. The hormone response element mimic sequence of GAS5 lncRNA is sufficient to induce apoptosis in breast cancer cells. Oncotarget 2016.
6. Li J., Zhang M., An G., Ma Q. LncRNA TUG1 acts as a tumor suppressor in human glioma by promoting cell apoptosis. Exp. Biol. Med. (Maywood) 2016.
7. Ramos A.D., Attenello F.J., Lim D.A. Uncovering the roles of long noncoding RNAs in neural development and glioma progression. Neurosci Lett. 2015.
8. Li J., Bian E.B., He X.J., Ma C.C., Zong G., Wang H.L., Zhao B. Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas. Int. J. Oncol. 2016, 48:723-733.
9. Pasmant E., Laurendeau I., Heron D., Vidaud M., Vidaud D., Bieche I. Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res. 2007, 67:3963-3969.
10. Yu W., Gius D., Onyango P., Muldoon-Jacobs K., Karp J., Feinberg A.P., Cui H. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 2008, 451:202-206.
11. Takayama K., Horie-Inoue K., Katayama S., Suzuki T., Tsutsumi S., Ikeda K., et al. Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer. EMBO J. 2013, 32:1665-1680.
12. Yang X., Song J.H., Cheng Y., Wu W., Bhagat T., Yu Y., Mori Y., et al. Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells. Gut 2014, 63:881-890.
13. Yuan S.X., Tao Q.F., Wang J., Yang F., Liu L., Wang L.L., Zhou W.P., et al. Antisense long non-coding RNA PCNA-AS1 promotes tumor growth by regulating proliferating cell nuclear antigen in hepatocellular carcinoma. Cancer Lett. 2014, 349:87-94.
14. Katayama S., Tomaru Y., Kasukawa T., Waki K., Nakanishi M., Nakamura M., Consortium F., et al. Antisense transcription in the mammalian transcriptome. Science 2005, 309:1564-1566.
15. Morris K.V., Vogt P.K. Long antisense non-coding RNAs and their role in transcription and oncogenesis. Cell Cycle 2010, 9:2544-2547.
16. Yao J., Zhou B., Zhang J., Geng P., Liu K., Zhu Y., Zhu W. A new tumor suppressor LncRNA ADAMTS9-AS2 is regulated by DNMT1 and inhibits migration of glioma cells. Tumour Biol. 2014, 35:7935-7944.
17. Celano P., Berchtold C.M., Kizer D.L., Weeraratna A., Nelkin B.D., Baylin S.B., Casero R.A. Characterization of an endogenous RNA transcript with homology to the antisense strand of the human c-myc gene. J. Biol. Chem. 1992, 267:15092-15096.
18. Coster G., Goldberg M. The cellular response to DNA damage: a focus on MDC1 and its interacting proteins. Nucleus 2010, 1:166-178.
19. d'Adda di Fagagna F., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., Von Zglinicki T., Jackson S.P., et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003, 426:194-198.
20. Jungmichel S., Stucki M. MDC1: the art of keeping things in focus. Chromosoma 2010, 119:337-349.
21. Lou Z., Minter-Dykhouse K., Wu X., Chen J. MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways. Nature 2003, 421:957-961.
22. Nakanishi M., Ozaki T., Yamamoto H., Hanamoto T., Kikuchi H., Furuya K., Nakagawara A., et al. NFBD1/MDC1 associates with p53 and regulates its function at the crossroad between cell survival and death in response to DNA damage. J. Biol. Chem. 2007, 282:22993-23004.
23. Stewart G.S., Wang B., Bignell C.R., Taylor A.M., Elledge S.J. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature 2003, 421:961-966.
24. Stucki M., Clapperton J.A., Mohammad D., Yaffe M.B., Smerdon S.J., Jackson S.P. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell 2005, 123:1213-1226.
25. Watanabe S., Watanabe K., Akimov V., Bartkova J., Blagoev B., Lukas J., Bartek J. JMJD1C demethylates MDC1 to regulate the RNF8 and BRCA1-mediated chromatin response to DNA breaks. Nat. Struct. Mol. Biol. 2013, 20:1425-1433.
26. Meng X.W., Koh B.D., Zhang J.S., Flatten K.S., Schneider P.A., Billadeau D.D., Kaufmann S.H., et al. Poly(ADP-ribose) polymerase inhibitors sensitize cancer cells to death receptor-mediated apoptosis by enhancing death receptor expression. J. Biol. Chem. 2014, 289:20543-20558.
27. Minter-Dykhouse K., Ward I., Huen M.S., Chen J., Lou Z. Distinct versus overlapping functions of MDC1 and 53BP1 in DNA damage response and tumorigenesis. J. Cell Biol. 2008, 181:727-735.
28. Bartkova J., Horejsi Z., Sehested M., Nesland J.M., Rajpert-De Meyts E., Skakkebaek N.E., Bartek J., et al. DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours. Oncogene 2007, 26:7414-7422.
29. Faghihi M.A., Wahlestedt C. Regulatory roles of natural antisense transcripts. Nat. Rev. Mol. Cell Biol. 2009, 10:637-643.
30. Wahlestedt C. Natural antisense and noncoding RNA transcripts as potential drug targets. Drug Discov. Today 2006, 11:503-508.
31. Yelin R., Dahary D., Sorek R., Levanon E.Y., Goldstein O., Shoshan A., Rotman G., et al. Widespread occurrence of antisense transcription in the human genome. Nat. Biotechnol. 2003, 21:379-386.
32. Yang Z., Bu Y., Wang C., Liu G., Song F. Growth inhibition, morphology change, and cell cycle alterations in NFBD1-depleted human esophageal cancer cells. Mol. Cell. Biochem. 2010, 342:1-6.
33. Yuan C., Bu Y., Wang C., Yi F., Yang Z., Huang X., Song F., et al. NFBD1/MDC1 is a protein of oncogenic potential in human cervical cancer. Mol. Cell. Biochem. 2012, 359:333-346.